Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and early-stage development of pharmaceuticals for.
Launch date
Employees
Market cap
AUD2.9b
Enterprise valuation
AUD2.6b (Public information from Sep 2024)
Share price
$103.68 LGND
San Diego California (HQ)
No columns specified